Suppr超能文献

以[³H] -育亨宾结合法表征犬血小板膜上的α₂ -肾上腺素能受体。

Alpha 2-adrenergic receptors on canine platelet membranes characterized by [3H]-yohimbine binding.

作者信息

O'Hara N, Yokota S, Kouchi Y, Ono H

出版信息

Res Commun Chem Pathol Pharmacol. 1986 May;52(2):179-94.

PMID:3012728
Abstract

Alpha 2-adrenoceptors on canine platelet membranes were characterized by [3H]-yohimbine binding. Binding of [3H]-yohimbine to the membranes was rapidly saturated, stable and reversible with high affinity. Dissociation constant (KD) calculated from Scatchard analysis of the equilibrium experiments was 1.89 +/- 0.20 nM which was in good agreement with KD (1.97 +/- 0.60 nM) obtained in the kinetic experiments. Maximal binding sites of the ligand (Bmax) was 249 +/- 20 fmoles/mg protein. Adrenergic antagonists inhibited the ligand binding in following rank order of potency; yohimbine greater than phentolamine greater than phenoxybenzamine greater than corynanthine greater than prazosin. This order was in good correlation with that for these drugs in the inhibition of platelet aggregation. Hill coefficients for the displacement curves of the ligand binding by adrenergic agonists were less than 1.0 which were converted into near unity in the presence of 5'-guanylyl-imidodiphosphate (100 microM). These results demonstrate that canine platelet membranes have alpha 2-adrenoceptors and suggest that the binding of these receptors to adrenergic agonists is regulated by guanine nucleotides.

摘要

通过[3H] -育亨宾结合对犬血小板膜上的α2 -肾上腺素能受体进行了表征。[3H] -育亨宾与膜的结合迅速饱和、稳定且具有高亲和力的可逆性。根据平衡实验的Scatchard分析计算的解离常数(KD)为1.89±0.20 nM,这与动力学实验中获得的KD(1.97±0.60 nM)非常一致。配体的最大结合位点(Bmax)为249±20 fmol/mg蛋白质。肾上腺素能拮抗剂按以下效力顺序抑制配体结合;育亨宾大于酚妥拉明大于酚苄明大于育亨烷大于哌唑嗪。该顺序与这些药物在抑制血小板聚集方面的顺序高度相关。肾上腺素能激动剂对配体结合位移曲线的希尔系数小于1.0,在5'-鸟苷酰-亚氨基二磷酸(100μM)存在下转变为接近1。这些结果表明犬血小板膜具有α2 -肾上腺素能受体,并表明这些受体与肾上腺素能激动剂的结合受鸟嘌呤核苷酸调节。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验